\-\ Texto\\:\\ \ \(0\)\
\-\ well\\ nourished\\ and\\ well\\ developed\\ male\\.\ \(0\)\
\-\ high\\ signal\\ involving\\ the\\ pachymeninges\\ diffusely\\ in\\ a\\ smooth\\ pattern\\ without\\ enhancement\\ of\\ the\\ leptomeninges\\ or\\ loss\\ of\\ the\\ grey\\-white\\ matter\\ differentiation\\.\\ there\\ is\\ diffuse\\ enhancement\\ with\\ contrast\\ administration\\ \\-\\ without\\ an\\ abnormal\\ focus\\,\\ nodularity\\,\\ or\\ rim\\ enhancing\\ lesion\\.\ \(0\)\
\-\ intracranial\\ hypotension\ \(1\)\
\-\ intracranial\\ hypotension\ \(1\)\
\-\ meningitis\\ \\(pachymeningitis\\)\ \(0\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ post\\ surgical\\ changes\\ with\\ dural\\ thickening\ \(0\)\
\-\ 40\\ yo\\ man\\ presents\\ with\\ a\\ three\\ week\\ history\\ of\\ headaches\\ that\\ exacerbate\\ with\\ position\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hypotension\\:\\ 0\\.3332678144427723\ \(0\)\
\-\ intracranial\\:\\ 0\\.24759674406320442\ \(0\)\
\-\ exacerbate\\:\\ 0\\.23511458259508564\ \(0\)\
\-\ pachymeninges\\:\\ 0\\.22735528154871762\ \(0\)\
\-\ pachymeningitis\\:\\ 0\\.22735528154871762\ \(0\)\
\-\ leptomeninges\\:\\ 0\\.2054830403569296\ \(0\)\
\-\ enhancement\\:\\ 0\\.17711472487399132\ \(0\)\
\-\ nodularity\\:\\ 0\\.17043904984208838\ \(0\)\
\-\ without\\:\\ 0\\.16230747705683723\ \(0\)\
\-\ nourished\\:\\ 0\\.15766023680184554\ \(0\)\
\-\ differentiation\\:\\ 0\\.14939677543014357\ \(0\)\
\-\ well\\:\\ 0\\.1489965542120238\ \(0\)\
\-\ meningitis\\:\\ 0\\.14491985881205488\ \(0\)\
\-\ diffusely\\:\\ 0\\.1430801600734742\ \(0\)\
\-\ dural\\:\\ 0\\.13653327851471206\ \(0\)\
\-\ focus\\:\\ 0\\.13032932317108922\ \(0\)\
\-\ smooth\\:\\ 0\\.127029625085155\ \(0\)\
\-\ position\\:\\ 0\\.12266254980411143\ \(0\)\
\-\ administration\\:\\ 0\\.1225238770457313\ \(0\)\
\-\ rim\\:\\ 0\\.1225238770457313\ \(0\)\
\-\ with\\:\\ 0\\.12050843047623182\ \(0\)\
\-\ matter\\:\\ 0\\.11714917795937974\ \(0\)\
\-\ pattern\\:\\ 0\\.11486851366976097\ \(0\)\
\-\ headaches\\:\\ 0\\.11476457599936332\ \(0\)\
\-\ developed\\:\\ 0\\.11414922325403963\ \(0\)\
\-\ 40\\:\\ 0\\.11315384121718022\ \(0\)\
\-\ involving\\:\\ 0\\.10776805808561364\ \(0\)\
\-\ or\\:\\ 0\\.10704816277815442\ \(0\)\
\-\ thickening\\:\\ 0\\.10467139250916505\ \(0\)\
\-\ week\\:\\ 0\\.10348486104876342\ \(0\)\
\-\ three\\:\\ 0\\.10328078598623697\ \(0\)\
\-\ diffuse\\:\\ 0\\.09648733005288353\ \(0\)\
\-\ enhancing\\:\\ 0\\.09638217673415633\ \(0\)\
\-\ yo\\:\\ 0\\.09612107312595393\ \(0\)\
\-\ loss\\:\\ 0\\.09373527191327102\ \(0\)\
\-\ changes\\:\\ 0\\.09298470404884832\ \(0\)\
\-\ abnormal\\:\\ 0\\.09243517484470835\ \(0\)\
\-\ the\\:\\ 0\\.09210008899914159\ \(0\)\
\-\ of\\:\\ 0\\.09032735228570697\ \(0\)\
\-\ high\\:\\ 0\\.08744219009974953\ \(0\)\
\-\ signal\\:\\ 0\\.0872171112517927\ \(0\)\
\-\ metastatic\\:\\ 0\\.0843828217744733\ \(0\)\
\-\ post\\:\\ 0\\.08371845833157326\ \(0\)\
\-\ man\\:\\ 0\\.08145376155623867\ \(0\)\
\-\ surgical\\:\\ 0\\.07477947991821828\ \(0\)\
\-\ contrast\\:\\ 0\\.07475593404846399\ \(0\)\
\-\ presents\\:\\ 0\\.07401311830016476\ \(0\)\
\-\ lesion\\:\\ 0\\.07376242810255493\ \(0\)\
\-\ male\\:\\ 0\\.0685030175478015\ \(0\)\
\-\ that\\:\\ 0\\.06676813160468438\ \(0\)\
\-\ disease\\:\\ 0\\.06458366746438844\ \(0\)\
\-\ there\\:\\ 0\\.06121918932599111\ \(0\)\
\-\ an\\:\\ 0\\.058834368164198986\ \(0\)\
\-\ history\\:\\ 0\\.058782248742974934\ \(0\)\
\-\ is\\:\\ 0\\.04213476171027796\ \(0\)\
\-\ in\\:\\ 0\\.03827460737330373\ \(0\)\
\-\ and\\:\\ 0\\.03179264799692315\ \(0\)\
